Skip to content

Supplier News

Study: Vichy product reduces acne blemishes

Vichy Laboratoires said a study by the L’Oreal Institute for Ethnic Hair and Skin Research found that acne was the top problem and biggest skin concern cited by Caucasian, African-American, Hispanic and Asian women and that Vichy Normaderm Anti-Imperfection Hydrating Care effectively addresses acne-

Par Pharma starts shipping generic Tussionex

Par Pharmaceutical Companies Inc. has begun limited shipment of hydrocodone polistirex and chlorpheniramine polistirex (CIII) extended-release oral suspension. The company said Tuesday that its licensing partner, Tris Pharma Inc.

MuscleCare helps relieve diabetic pain

All-natural topical pain reliever MuscleCare, designed to alleviate aching muscles, also can assist in easing the pain associated with diabetes, according to Dr. Chris Oswald, founder and chief executive officer of Active and Innovative Inc., which markets the product.

Carlyle Group wraps up acquisition of NBTY

Asset management firm The Carlyle Group has completed its $4 billion acquisition of nutritional supplements maker and marketer NBTY Inc. Under the merger agreement, NBTY stockholders receive $55 in cash for each share of NBTY common stock owned by them.

Novo Nordisk, Walgreens team with UnitedHealth on diabetes

Diabetes care provider Novo Nordisk is joining UnitedHealth Group’s Diabetes Prevention and Control Alliance, a national partnership that provides access to community- and evidence-based interventions to help prevent and control diabetes, prediabetes and obesity.

Valeant, Biovail wrap up merger

Valeant Pharmaceuticals International Inc. announced that it has completed its merger with Biovail Corp. after shareholders of both companies approved the agreement. The specialty pharmaceutical makers unveiled the deal to merge in late June.